trial · primary record
IMA203
Melanoma, Cutaneous Malignant
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 450 |
| Primary completion | 2032-08-12 |
| Primary endpoint | Progression-free survival assessed by BICR |
| Registry ID | NCT06743126 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:05.456Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06743126
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.